Anti-ADIPL/ C1QTNF12/ C1QDC2 functional antibody

Anti-ADIPL/ C1QTNF12/ C1QDC2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to C1QTNF12/C1QTNF12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0712-Ab-1/ GM-Tg-hg-SE0712-Ab-2Anti-Human C1QTNF12 monoclonal antibodyHuman
GM-Tg-rg-SE0712-Ab-1/ GM-Tg-rg-SE0712-Ab-2Anti-Rat C1QTNF12 monoclonal antibodyRat
GM-Tg-mg-SE0712-Ab-1/ GM-Tg-mg-SE0712-Ab-2Anti-Mouse C1QTNF12 monoclonal antibodyMouse
GM-Tg-cynog-SE0712-Ab-1/ GM-Tg-cynog-SE0712-Ab-2Anti-Cynomolgus/ Rhesus macaque C1QTNF12 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0712-Ab-1/ GM-Tg-felg-SE0712-Ab-2Anti-Feline C1QTNF12 monoclonal antibodyFeline
GM-Tg-cang-SE0712-Ab-1/ GM-Tg-cang-SE0712-Ab-2Anti-Canine C1QTNF12 monoclonal antibodyCanine
GM-Tg-bovg-SE0712-Ab-1/ GM-Tg-bovg-SE0712-Ab-2Anti-Bovine C1QTNF12 monoclonal antibodyBovine
GM-Tg-equg-SE0712-Ab-1/ GM-Tg-equg-SE0712-Ab-2Anti-Equine C1QTNF12 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0712-Ab-1/ GM-Tg-hg-SE0712-Ab-2; GM-Tg-rg-SE0712-Ab-1/ GM-Tg-rg-SE0712-Ab-2;
GM-Tg-mg-SE0712-Ab-1/ GM-Tg-mg-SE0712-Ab-2; GM-Tg-cynog-SE0712-Ab-1/ GM-Tg-cynog-SE0712-Ab-2;
GM-Tg-felg-SE0712-Ab-1/ GM-Tg-felg-SE0712-Ab-2; GM-Tg-cang-SE0712-Ab-1/ GM-Tg-cang-SE0712-Ab-2;
GM-Tg-bovg-SE0712-Ab-1/ GM-Tg-bovg-SE0712-Ab-2; GM-Tg-equg-SE0712-Ab-1/ GM-Tg-equg-SE0712-Ab-2
Products NameAnti-C1QTNF12 monoclonal antibody
Formatmab
Target NameC1QTNF12
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-C1QTNF12 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0712-Ag-1Recombinant multi-species ADIPL/ C1QTNF12/ C1QDC2 protein


    Target information

    Target IDGM-SE0712
    Target NameC1QTNF12
    Gene ID388581,67389,313774,722375,100683774,101083498,506102,100066088
    Gene Symbol and Synonyms1110035L05Rik,alipolin,C1QDC2,C1QTNF12,CTRP12,FAM132A,RGD1307059
    Uniprot AccessionQ5T7M4
    Uniprot Entry NameADIPL_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000184163
    Target ClassificationN/A

    The target: C1QTNF12, gene name: C1QTNF12, also named as C1QDC2, CTRP12, FAM132A. Predicted to enable hormone activity. Predicted to be involved in negative regulation of gluconeogenesis; positive regulation of glucose import; and positive regulation of insulin receptor signaling pathway. Predicted to act upstream of or within negative regulation of inflammatory response; positive regulation of cell communication; and regulation of glucose metabolic process. Predicted to be located in extracellular region. Predicted to be active in extracellular space. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.